scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company focused on revolutionizing cardiorenal healthcare through patient-centric innovations, has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference.

John Tucker, President & Chief Executive Officer, will deliver a presentation on Wednesday, February 12 at 2:40PM ET. The presentation will be accessible via webcast through the company's website under the Investor Relations section's 'News & Events' tab.

02/05/2025 - 04:01 PM

BURLINGTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President & Chief Executive Officer, will present at the Oppenheimer 35^th Annual Healthcare Life Sciences Conference on Wednesday, February 12 at 2:40PM ET.

A webcast of the presentation can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com.

About scPharmaceuticals

At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.

Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com

Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com

FAQ

When is scPharmaceuticals (SCPH) presenting at the Oppenheimer Healthcare Conference 2025?

scPharmaceuticals will present at the Oppenheimer Healthcare Conference on Wednesday, February 12, 2025, at 2:40PM ET.

How can investors watch scPharmaceuticals' (SCPH) Oppenheimer Conference presentation?

Investors can access the webcast through scPharmaceuticals' website under the 'News & Events' section in Investor Relations, or through the direct webcast link provided.